Organic chemistry

Antibiotics and bioactive compounds

Antibiotics and other bioactive compounds work by selectively interfering with microbial or cellular processes, and their use drives the evolution of resistance.

IntuitionIntuition: a selective advantage becomes a selective vulnerability

A molecule can be useful as a drug when it blocks a target that matters to a pathogen but not, or much less, to the host. The problem is dynamic: exposure selects organisms that carry or acquire resistance, so every antibiotic is part of an evolving ecological system rather than a permanent technical solution.

SchoolSchool level: what makes a compound bioactive

Antibiotics are a special subset: they selectively inhibit or kill bacteria. Natural-product antibiotics often began as microbial defence metabolites; semisynthetic and fully synthetic analogues were developed to improve spectrum, stability, uptake, or safety.

UndergraduateUniversity: why resistance emerges

Resistance can arise by target mutation, enzymatic inactivation, reduced uptake, increased efflux, or acquisition of resistance genes on mobile genetic elements. Selection pressure does not create mutations directly; it changes which organisms survive and reproduce.

A drug’s spectrum is the range of organisms it affects. Broad-spectrum agents can be clinically useful but also disturb normal microbiota; narrow-spectrum agents may reduce collateral damage but require better identification of the pathogen.

AdvancedAdvanced: discovery is a moving target

Screening once meant testing soil microbes and their extracts; now it includes genome mining, structure-guided design, target-based assays, phenotypic screening and data-driven prioritization. Even with a strong hit, medicinal chemistry must solve potency, solubility, permeability, toxicity and manufacturability at the same time.